Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
スポンサーリンク
概要
- 論文の詳細を見る
Coxsackie virus B3 (CVB3) is believed to be a major contributor to viral myocarditis since virus-associated apoptosis plays a role in the pathogenesis of experimental myocarditis. In this study, we investigated the in vitro and in vivo antiviral activities of Phyllaemblicin B, the main ellagitannin compound isolated from Phyllanthus emblica, a Chinese herb medicine, against CVB3. Herein we report that Phyllaemblicin B inhibited CVB3-mediated cytopathic effects on HeLa cells with an IC(50) value of 7.75+/-0.15microg/mL. In an in vivo assay, treatment with 12mgkg(-1)d(-1) Phyllaemblicin B reduced cardiac CVB3 titers, decreased the activities of LDH and CK in murine serum, and alleviated pathological damages of cardiac muscle in myocarditic mice. Moreover, Phyllaemblicin B clearly inhibited CVB3-associated apoptosis effects both in vitro and in vivo. These results show that Phyllaemblicin B exerts significant antiviral activities against CVB3. Therefore, Phyllaemblicin B may represent a potential therapeutic agent for viral myocarditis.
論文 | ランダム
- 報告1 (東京大学社会科学研究所編『現代日本社会6問題の諸相』)
- 磁力式膜厚測定-電磁式膜厚計, 永久磁石式膜厚計-
- トランスピュータを用いたコミティマシンとその応用
- 分化度からみた肺腺癌化学療法の問題点 (肺疾患)
- 伊藤忠商事 新しい経営環境に適したインフラ作り (特集 四半期開示わが社の取組み)